✦ LIBER ✦

A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors

✍ Scribed by Gordon, Michael S.; Rosen, Lee S.; Mendelson, David; Ramanathan, Ramesh K.; Goldman, Jonathan; Liu, Lili; Xu, Yan; Gerson, Stanton L.; Anthony, Stephen P.; Figg, William D.; Spencer, Shawn; Adams, Bonne J.; Theuer, Charles P.; Leigh, Bryan R.; Weiss, Glen J.

Book ID: 121637898
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 224 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9876-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase Ib trial of the oral angiogenesis

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors

✍ Jeffrey R. Infante, Silvia Novello, Wen Wee Ma, Grace K. Dy, Johanna C. Bendell, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 265 KB

Phase 1 study of MLN8054, a selective in

Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors

✍ E. Claire Dees; Jeffrey R. Infante; Roger B. Cohen; Bert H. O’Neil; Suzanne Jone 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 328 KB

A phase 1 and dose-finding study of LY25

A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors

✍ Wakui, Hiroshi; Yamamoto, Noboru; Kitazono, Satoru; Mizugaki, Hidenori; Nakamich 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 366 KB

1454 POSTER A phase I dose-finding study

1454 POSTER A phase I dose-finding study of pemetrexed combined with paclitaxel in patients with advanced solid tumors

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

367 A first-in-human Phase 1 study of an

367 A first-in-human Phase 1 study of anti-CD105 antibody therapy with TRC105 in patients with advanced solid tumors

✍ L. Rosen; M.S. Gordon; H.I. Hurwitz; M.K. Wong; J. Goldman; B.J. Adams; D. Alvar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Phase 1 study of the investigational, or

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors

✍ Yasuhito Fujisaka; Yasuhide Yamada; Noboru Yamamoto; Toshio Shimizu; Yutaka Fuji 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 364 KB